Here's How Much $100 Invested In Halozyme Therapeutics 5 Years Ago Would Be Worth Today
Halozyme Therapeutics (NASDAQ:HALO) has outperformed the market over the past 5 years by 12.8% on an annualized basis producing an average annual return of 24.48%. Currently, Halozyme Therapeutics has a market
Halozyme stock grew faster than most stocks over five years. When a company does well for a long time, it shows people trust the business.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.